Featured Entrepreneurs

Since 2010, MassChallenge has accelerated 1,975 startups that have raised more than $4.3 billion in funding, generated more than $2.5 billion in revenue, and created more than 121,000 total jobs. 

Our startups

Be inspired. Search our startups.

Clear  
ViThera Laboratories
ViThera Laboratories

ViThera develops new drugs based on engineered beneficial bacteria. Our lead product VT201 targets IBD, such as Crohn's or Colitis, a significant unmet need, and addresses a $10bn/yr market. VT201 is a food strain bacterium (Lactococcus Lactis, typical component of cheese) engineered to express an anti-inflammatory protein which controls inflammation in the gut-after oral intake of the therapeutic bacteria. We have a uniquely experienced team and strong exclusive IP position.
ViThera develops new drugs based on engineered beneficial bacteria

Connect with ViThera Laboratories

2010

2010 Silver Boston

2010 Top 26

Sub industry

Healthcare / Life Sciences

Mission

MassChallenge strengthens the global innovation ecosystem by accelerating high-potential startups across all industries, from anywhere in the world.